IHS Chemical Week

Regions :: India/Pakistan

Hospira completes acquisition of Orchid's API manufacturing and R&D facilities in India for $218 million

8:40 PM MDT | July 4, 2014 | Deepti Ramesh

Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, announced on 4 July that it has completed the previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceuticals company, for about $218 million. The API manufacturing facility is located at Aurangabad, India and the associated R&D facility is located at Chennai. Plans...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa